Morning Trading June 21, page-3

  1. Rexy789
    3,834 Posts.
    lightbulb Created with Sketch. 145
    clock Created with Sketch.
    21/06/23
    09:50
    Post #: 68392534
    IBX

    pleased to report that the MagSense® HER2 imaging agent Phase 1 study (IBI10103) has achieved its enrolment target and that the Company has iniƟated its plans to close the study as was indicated in the Company’s AGM held on 25th May 2023.
    Likes Created with Sketch.  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.